ARYA Sciences Acquisition Corp II

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $149.50M
IPO Date Jun 5, 2020
CEO Adam Stone
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences and medical technologies in North America and Europe

IPO Geography Global
Target Company Cerevel Therapeutics
Deal Announced Jul 30, 2020
Deal Size, $M $847.37M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Oct 26, 2020
Amendment Vote TBD
Closing Date Oct 27, 2020
Formerly ARYB CERE CEREW

Sign up for Free Trial

No credit card required

Sign in for more on ARYA Sciences Acquisition Corp II:

  • Structure and cap table
  • 7 directors & officers
  • 21 filings and events
  • 2 underwriters
  • 7 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Joseph Edelman 64 Chairman
Adam Stone 40 CEO and Director
Michael Altman 38 CFO and Director
Konstantin Poukalov 36 Chief Business Officer
Jake Bauer 41 Director
Dr. Todd Wider 55 Director
Chad Robins 46 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies Joint BR 6,500,000 units
Goldman Sachs Joint BR 6,500,000
13,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 21 filings.

Shareholders

Sign in to view shareholders 13F filing data.